ContractClinical Study Agreement • October 11th, 2023
Contract Type FiledOctober 11th, 2023CLINICAL STUDY AGREEMENT ZMLUVA O KLINICKOM SKÚŠANÍ PROTOCOL: OP0595-5 PROTOKOL: OP0595-5 SITE: ME5-11-01 PRACOVISKO: ME5-11-01 Č MEIJISEIKA PHARMA CO., LTD. MEIJISEIKA PHARMA CO., LTD. 26-SEP-2023 26-09-2023 VERSION: VERSION#1 VERZIA:VERZIAČ. 1 COUNTRY: SLOVAKIA KRAJINA: SLOVENSKO CLINICAL STUDY AGREEMENT ZMLUVA O KLINICKOM SKÚŠANÍ This clinical study agreement (“Agreement”), effective as of 26-SEP-2023 however, no earlier than the day following the day of its publication in the Central Register of Contracts of the Slovak Republic (the “Effective Date”), is entered into by and among Medpace Clinical Research, LLC, with its principal office and place of business at 5375 Medpace Way, Cincinnati, Ohio 45227, tax ID 81-4138570 (“Medpace”), representedClinical Trial Manager; and Fakultna nemocnica s poliklinikou F. D. Roosevelta Banska Bystrica, a clinical research site with its principal office and place of business at Nam. L. Svobodu 1, 975 17 Banska Bystrica, Slovakia, ID No.: 0